Cargando…
Rational Identification of Enoxacin as a Novel V-ATPase-Directed Osteoclast Inhibitor
Binding between vacuolar H(+)-ATPases (V-ATPases) and microfilaments is mediated by an actin binding domain in the B-subunit. Both isoforms of mammalian B-subunit bind microfilaments with high affinity. A similar actin-binding activity has been demonstrated in the B-subunit of yeast. A conserved “pr...
Autores principales: | Toro, Edgardo J, Ostrov, David A, Wronski, Thomas J, Holliday, L Shannon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409362/ https://www.ncbi.nlm.nih.gov/pubmed/22044158 http://dx.doi.org/10.2174/138920312800493151 |
Ejemplares similares
-
Bis-Enoxacin Blocks Rat Alveolar Bone Resorption from Experimental Periodontitis
por: Rivera, Mercedes F., et al.
Publicado: (2014) -
Enoxacin and bis-enoxacin stimulate 4T1 murine breast cancer cells to release extracellular vesicles that inhibit osteoclastogenesis
por: Vracar, Taylor C., et al.
Publicado: (2018) -
V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis
por: Duan, Xiaohong, et al.
Publicado: (2018) -
Bisphosphonate‐enoxacin inhibit osteoclast formation and function by abrogating RANKL‐induced JNK signalling pathways during osteoporosis treatment
por: Xu, Qiang, et al.
Publicado: (2021) -
In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection
por: Ahmadi, Amirhossein, et al.
Publicado: (2021)